The ANIP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ANIP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ANIP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ANIP Detailed Price Forecast - CNN Money||View ANIP Detailed Summary - Google Finance|
|View ANIP Detailed Summary - Yahoo! Finance||View ANIP Stock Research & Analysis - Zacks.com|
|View ANIP Trends & Analysis - Trade-Ideas||View ANIP Major Holders - Barrons|
|View ANIP Call Transcripts - NASDAQ||View ANIP Breaking News & Analysis - Seeking Alpha|
|View ANIP Annual Report - CompanySpotlight.com||View ANIP OTC Short Report - OTCShortReport.com|
|View ANIP Fundamentals - TradeKing||View ANIP SEC Filings - Bar Chart|
|View Historical Prices for ANIP - The WSJ||View Performance/Total Return for ANIP - Morningstar|
|View the Analyst Estimates for ANIP - MarketWatch||View the Earnings History for ANIP - CNBC|
|View the ANIP Earnings - StockMarketWatch||View ANIP Buy or Sell Recommendations - MacroAxis|
|View the ANIP Bullish Patterns - American Bulls||View ANIP Short Pain Metrics - ShortPainBot.com|
|View ANIP Stock Mentions - StockTwits||View ANIP Stock Mentions - PennyStockTweets|
|View ANIP Stock Mentions - Twitter||View ANIP Investment Forum News - Investor Hub|
|View ANIP Stock Mentions - Yahoo! Message Board||View ANIP Stock Mentions - Seeking Alpha|
|View Insider Transactions for ANIP - SECform4.com||View Insider Transactions for ANIP - Insider Cow|
|View ANIP Major Holdings Summary - CNBC||View Insider Disclosure for ANIP - OTC Markets|
|View Insider Transactions for ANIP - Yahoo! Finance||View Institutional Holdings for ANIP - NASDAQ|
|View ANIP Stock Insight & Charts - FinViz.com||View ANIP Investment Charts - StockCharts.com|
|View ANIP Stock Overview & Charts - BarChart||View ANIP User Generated Charts - Trading View|
ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution
Posted on Wednesday April 18, 2018
BAUDETTE, Minn., April 18, 2018 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (ANIP) today announced that it has received approval from the U.S. Food and Drug Administration ("FDA") of its Abbreviated New Drug Application ("ANDA") for Morphine Sulfate Oral Solution 10mg/5mL, 20mg/5mL and 100mg/5mL. ANI expects to begin shipping product to its customers in the near future. Arthur S. Przybyl, ANI's President and CEO stated, "We are pleased to announce the approval of this internally developed generic product, which leverages both our liquid manufacturing and controlled substance capabilities.
ANI Acquires 23 ANDAs from IDT Australia, Ltd.
Posted on Wednesday April 04, 2018
BAUDETTE, Minn., April 4, 2018 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (ANIP) today announced that it has acquired ANDAs for 23 previously marketed generic drug products from IDT Australia, Ltd. ("IDT") for $2.6 million and a limited single-digit royalty for one product. Additionally, ANI acquired active pharmaceutical ingredient for one of the acquired products for $135 thousand. In 2015, ANI had secured the U.S. licensing rights and 40% to 50% of the net profits upon commercialization for these products from IDT for $1.0 million. Today's acquisition gives ANI full control of the re-commercialization program and the vast majority of the economics for these products. Arthur S. Przybyl, President and CEO of ANI stated, "This acquisition advances our strategy of building a pipeline of previously approved generic drug products that can be re-commercialized via a CBE-30 (changes being effected in thirty days) or prior approval supplement filing.
Is ANI Pharmaceuticals Inc (NASDAQ:ANIP) A Financially Sound Company?
Posted on Tuesday April 03, 2018
Investors are always looking for growth in small-cap stocks like ANI Pharmaceuticals Inc (NASDAQ:ANIP), with a market cap of US$678.34M. However, an important fact which most ignore is: how financiallyRead More...
Where ANI Pharmaceuticals Inc’s (NASDAQ:ANIP) Earnings Growth Stands Against Its Industry
Posted on Thursday March 15, 2018
After looking at ANI Pharmaceuticals Inc’s (NASDAQ:ANIP) latest earnings announcement (31 December 2017), I found it useful to revisit the company’s performance in the past couple of years and assessRead More...